1.
J Postgrad Med
;
2007 Apr-Jun; 53(2): 135-8
Article
in English
| IMSEAR
| ID: sea-115733
ABSTRACT
Rapid advances in the treatment of breast cancer, especially in the form of hormone therapy have truly increased the hope of longer and better disease-free survival for these patients. Exemestane, a third generation aromatase inhibitor has been extensively evaluated in metastatic as well as adjuvant therapy of breast cancer. It has also been evaluated for its safety profile, especially on bone and lipids. Exemestane provides hope to the patients with breast cancer both in early and metastatic disease. This review analyzes all the aspects of exemestane therapy.
Subject(s)
Androstadienes/adverse effects , Animals , Antineoplastic Agents/adverse effects , Aromatase Inhibitors/adverse effects , Breast Neoplasms/drug therapy , Female , Humans
2.
J Postgrad Med
;
2001 Jan-Mar; 47(1): 77-8
Article
in English
| IMSEAR
| ID: sea-115696